A-25
Regenerative Medicine Unit
7F
0713
Development of novel musculoskeletal regenerative medicine using new cell biology and tissue engineering methods
We are developing novel medical device of meniscus regeneration using atelocollagen, which is now under clinical trial with our patents. Moreover, we are aiming to develop hybrid treatment methods using this atelocollagen and musculoskeletal stem cells, and other musculoskeletal regenerative medicine using novel nano-technology in cooperation with collaborating company.
Responsible Departments
Department of Musculoskeletal Regenerative Medicine
Research Partner
Taisho Pharmaceutical Co., Ltd.
Project Members
Principal Investigator
Members
Specially Appointed Assistant Professor
Department of Musculoskeletal Regenerative Medicine
ProfileJoint Research Collaborator
Taisho Pharmaceutical Co., Ltd.
Links
Taisho Pharmaceutical Co., Ltd.
https://www.taisho.co.jp/global/